These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3768017

  • 1. Hyperprolactinaemia does not alter specific striatal 3H-spiperone binding in the rat.
    Simpson MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1986 Oct 01; 35(19):3203-8. PubMed ID: 3768017
    [Abstract] [Full Text] [Related]

  • 2. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM, Kilpatrick G, Hall MD, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1984 Oct 01; 84(4):512-9. PubMed ID: 6441952
    [Abstract] [Full Text] [Related]

  • 3. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
    Jenner P, Rupniak NM, Marsden CD.
    Psychopharmacology Suppl; 1985 Oct 01; 2():174-81. PubMed ID: 3159009
    [Abstract] [Full Text] [Related]

  • 4. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR, Dubocovich ML.
    J Pharmacol Exp Ther; 1983 Dec 01; 227(3):592-9. PubMed ID: 6655559
    [Abstract] [Full Text] [Related]

  • 5. Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the rat.
    Simpson MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1986 Oct 15; 35(20):3501-6. PubMed ID: 3768037
    [Abstract] [Full Text] [Related]

  • 6. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
    Morgan DG, Sinha YN, Finch CE.
    Neuroendocrinology; 1984 May 15; 38(5):407-10. PubMed ID: 6728123
    [Abstract] [Full Text] [Related]

  • 7. Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivity.
    Rupniak N, Hong M, Mansfield S, Fleminger S, Dyer R, Jenner P, Marsden CD.
    Eur J Pharmacol; 1983 Sep 30; 93(3-4):195-200. PubMed ID: 6139285
    [Abstract] [Full Text] [Related]

  • 8. Effect of chronic sulpiride on striatal spiperone binding.
    Bannet J, Gillis S, Ebstein RP, Belmaker RH.
    Int Pharmacopsychiatry; 1980 Sep 30; 15(6):334-7. PubMed ID: 7298264
    [Abstract] [Full Text] [Related]

  • 9. Effect of estradiol and haloperidol on hypophysectomized rat brain dopamine receptors.
    Di Paolo T, Daigle M, Labrie F.
    Psychoneuroendocrinology; 1984 Sep 30; 9(4):399-404. PubMed ID: 6514934
    [Abstract] [Full Text] [Related]

  • 10. Tumors producing chronic hyperprolactinemia do not alter [3H]spiperone binding and dopamine turnover in the corpus striatum of the female rat.
    Cronin MJ, Reches A, MacLeod RM, Login IS.
    Eur J Pharmacol; 1983 Jul 22; 91(2-3):229-34. PubMed ID: 6617744
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.
    Rupniak NM, Mann S, Hall MD, Fleminger S, Kilpatrick G, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1984 Jul 22; 84(4):503-11. PubMed ID: 6441951
    [Abstract] [Full Text] [Related]

  • 12. Ovine prolactin administration modifies [3H]spiperone binding to striatal membranes of rabbits.
    Eva C, Blengio M, Ferretti C, Muccioli G, Portaleone P.
    Brain Res; 1982 Nov 18; 251(2):388-90. PubMed ID: 7139336
    [Abstract] [Full Text] [Related]

  • 13. The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes.
    Kilpatrick GJ, Jenner P, Marsden CD.
    Eur J Pharmacol; 1984 Dec 15; 107(1):71-8. PubMed ID: 6084599
    [Abstract] [Full Text] [Related]

  • 14. Dopamine receptor binding sites in the rat superior colliculus.
    Chivers JK, Hall MD, Kelly E, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1984 Jul 15; 36(7):484-8. PubMed ID: 6146700
    [Abstract] [Full Text] [Related]

  • 15. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 15; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 16. Prolactin and estradiol increase striatal dopamine receptor density in intact, castrated and hypophysectomized rats.
    Di Paolo T, Poyet P, Labrie F.
    Prog Neuropsychopharmacol Biol Psychiatry; 1982 Feb 15; 6(4-6):377-82. PubMed ID: 6891804
    [Abstract] [Full Text] [Related]

  • 17. Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide.
    Tecott LH, Kwong LL, Uhr S, Peroutka SJ.
    Biol Psychiatry; 1986 Oct 15; 21(12):1114-22. PubMed ID: 2428411
    [Abstract] [Full Text] [Related]

  • 18. Comparison of neuroleptic binding characteristics in rat striatum and renal cortex.
    Hietala J, Syvälahti E, Röyttä M.
    J Recept Res; 1988 Oct 15; 8(6):753-71. PubMed ID: 3193400
    [Abstract] [Full Text] [Related]

  • 19. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP, Wooten GF.
    Ann Neurol; 1986 Apr 15; 19(4):378-83. PubMed ID: 3707090
    [Abstract] [Full Text] [Related]

  • 20. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA, Masotto C, Ongini E, Racagni G.
    Eur J Pharmacol; 1985 Jun 07; 112(2):187-93. PubMed ID: 2863153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.